Open original FDA record ↗Recall record
- FDA identifier
- Z-1506-2025
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Apr 1, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.
Source facts
- Action
- Medtronic issued an URGENT: MEDICAL DEVICE correction notice to its consignees on 02/28/2025 via email or US mail. The notice explained the issue and provided recommendations to temporarily mitigate the problem, and requested the following: Actions " Share this notice with all those who need to be aware of this issue within your organization and maintain a copy of this notice in your records. " Please provide a copy of the attached patient letter to your affected patients. " Please complete and return the Customer Confirmation Form enclosed with this letter, acknowledging that you have received this information. The form may be emailed to neuro.quality@medtronic.com. For questions regarding this communication, please contact Medtronic Technical Services at 1-800-707-0933 or your local Medtronic representative.
- Initiated
- 2025-01-09
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Canary Islands, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, United Kingdom.
- Recall number
- Z-1506-2025
- Recall status
- Open, Classified
- CDRH record ID
- 212397
- FDA classified
- 2025-04-01
- Recall event number
- 96237